LONDON – Newco Balmes Transplantation SAS added a further €700,000 (US$872,000) to its initial €900,000 seed funding, providing the means to reach proof of concept in animal models of kidney damage caused by ischemia reperfusion injury (IRI) following transplantation and also in IRI associated with cardiac surgery.